総説

The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence

Andrew J Weickhardt, D Ross Camidge

• 抽象的な

総説

Impact of recent landmark clinical trials on hypertension treatment

Ikechi G Okpechi, Brian L Rayner

• 抽象的な

総説

y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data

Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto

• 抽象的な

総説

Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia

John Muscedere

• 抽象的な

総説

Triple-negative breast cancer and new treatment developments

Stephen Dyar, Alvaro Moreno-Aspitia

• 抽象的な

総説

BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety

Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu

• 抽象的な

総説

The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes

Beau M Hawkins, Jorge F Saucedo, Sunil V Rao

• 抽象的な

総説

Medical therapy for renal artery stenosis

William R Colyer Jr, Christopher J Cooper

• 抽象的な

治療の見通し

New advances in the treatment of Friedreich ataxia: promises and pitfalls

Wolfgang Nachbauer, Sylvia Boesch

• 抽象的な